Pharming Group (Pharming Group) ROE % Adjusted to Book Value : -1.66% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Pharming Group ROE % Adjusted to Book Value?

Pharming Group's ROE % for the quarter that ended in Dec. 2023 was -5.83%. Pharming Group's PB Ratio for the quarter that ended in Dec. 2023 was 3.51. Pharming Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -1.66%.

Pharming Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Pharming Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group ROE % Adjusted to Book Value Chart

Pharming Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

4.74

2.82

1.94

-1.42

Pharming Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-8.17	-5.43	0.69	1.89	-1.66

Competitive Comparison of Pharming Group's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Pharming Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharming Group's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pharming Group's ROE % Adjusted to Book Value falls into.

Pharming Group ROE % Adjusted to Book Value Calculation

Pharming Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-4.98%	/	3.51
	=	-1.42%

Pharming Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-5.83%	/	3.51
	=	-1.66%

Pharming Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Pharming Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group (Pharming Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (NAS:PHAR) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

PHGUF:USA PHARM:Netherlands PHARMa:UK 0QCO:UK PHGN:Germany

Address

Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website

https://www.pharming.com

Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.